Zymeworks Inc. - Product Pipeline Review - 2015

  • ID: 3446791
  • Company Profile
  • 35 pages
  • Global Markets Direct
  • Zymeworks Inc
1 of 4
Zymeworks Inc. - Product Pipeline Review - 2015

Summary

The report ‘Zymeworks Inc. - Product Pipeline Review - 2015’, provides an overview of the Zymeworks Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Zymeworks Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Zymeworks Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Zymeworks Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Zymeworks Inc.’s pipeline products

Reasons to buy

- Evaluate Zymeworks Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Zymeworks Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Zymeworks Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Zymeworks Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Zymeworks Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Zymeworks Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Zymeworks Inc. Snapshot

Zymeworks Inc. Overview

Key Information

Key Facts

Zymeworks Inc. - Research and Development Overview

Key Therapeutic Areas

Zymeworks Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Zymeworks Inc. - Pipeline Products Glance

Zymeworks Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Zymeworks Inc. - Drug Profiles

ZW-25

Product Description

Mechanism of Action

R&D Progress

ZW-33

Product Description

Mechanism of Action

R&D Progress

ZW-38

Product Description

Mechanism of Action

R&D Progress

ZW-39

Product Description

Mechanism of Action

R&D Progress

ZW-9

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibodies for Cancer and Autoimmune Disease

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody Conjugated for Colorectal Cancer

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody Conjugated for Lung Cancer

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Autoimmune Disease

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Cancer, Autoimmune and Inflammatory Diseases

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Solid Tumors

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody to Modulate T-Cell for Solid Tumors

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody to Target T-Cell Receptor for Colorectal Cancer

Product Description

Mechanism of Action

R&D Progress

Zymeworks Inc. - Pipeline Analysis

Zymeworks Inc. - Pipeline Products by Target

Zymeworks Inc. - Pipeline Products by Molecule Type

Zymeworks Inc. - Pipeline Products by Mechanism of Action

Zymeworks Inc. - Recent Pipeline Updates

Zymeworks Inc. - Dormant Projects

Zymeworks Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Zymeworks Inc., Key Information

Zymeworks Inc., Key Facts

Zymeworks Inc. - Pipeline by Indication, 2015

Zymeworks Inc. - Pipeline by Stage of Development, 2015

Zymeworks Inc. - Monotherapy Products in Pipeline, 2015

Zymeworks Inc. - Out-Licensed Products in Pipeline, 2015

Zymeworks Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015

Zymeworks Inc. - Preclinical, 2015

Zymeworks Inc. - Discovery, 2015

Zymeworks Inc. - Pipeline by Target, 2015

Zymeworks Inc. - Pipeline by Molecule Type, 2015

Zymeworks Inc. - Pipeline Products by Mechanism of Action, 2015

Zymeworks Inc. - Recent Pipeline Updates, 2015

Zymeworks Inc. - Dormant Developmental Projects,2015

Zymeworks Inc., Other Locations

List of Figures

Zymeworks Inc. - Pipeline by Top 10 Indication, 2015

Zymeworks Inc. - Pipeline by Stage of Development, 2015

Zymeworks Inc. - Monotherapy Products in Pipeline, 2015

Zymeworks Inc. - Pipeline by Top 10 Target, 2015

Zymeworks Inc. - Pipeline by Top 10 Molecule Type, 2015

Zymeworks Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll